~~<i id='B2A9AFA424'><strike id='B2A9AFA424'><tt id='B2A9AFA424'><pre id='B2A9AFA424'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：focus 2025-09-28 06:02:25 Page View：97

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Testing for cancer recurrence creates a new limbo for patients
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

explore

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Chimpanzees, like humans and whales, get menopause: Study

GUERCHOMNDEBO/AFPviaGettyImagesChimpanzees—they’rejustlikeus.Femalechimps,itturnsout,gothroughmenopa

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Hospitals warn Medicare's drug payment fix is ‘unlawful’

AdobeHospitalsaretellinggovernmentofficialsitwouldbeillegaltoclawback$7.8billionaspartofaremedythati